tiprankstipranks
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
US Market
SXTC
China SXT Pharmaceuticals
RESEARCH TOOLSreports
Want to see SXTC full AI Analyst Report?

China SXT Pharmaceuticals (SXTC) Income Statement

302 Followers

China SXT Pharmaceuticals Income Statement

Last quarter (Q4 2025), China SXT Pharmaceuticals's total revenue was $455.71K, a decrease of -7.84% from the same quarter last year. In Q4, China SXT Pharmaceuticals's net income was $-1.25M. See China SXT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 1.74M$ 1.93M$ 1.97M$ 2.60M$ 4.78M
Gross Profit
$ 367.43K$ 553.97K$ 426.27K$ 1.25M$ 2.84M
Operating Expenses
$ 3.05M$ 3.07M$ 6.03M$ 6.44M$ 5.04M
Depreciation and Amortization
$ 82.30K$ 203.25K$ 250.16K$ 320.01K$ 345.41K
EBITDA
$ -2.57M$ -2.35M$ -5.21M$ -5.05M$ -1.85M
Operating Income
$ -2.68M$ -2.52M$ -5.61M$ -5.19M$ -2.20M
Other Income/Expenses
$ -623.17K$ -583.32K$ -327.26K$ -218.28K$ -743.79K
Pretax Income
$ -3.30M$ -3.10M$ -5.93M$ -5.41M$ -2.94M
Net Income
$ -3.30M$ -3.10M$ -5.93M$ -5.74M$ -2.75M
Per Share Metrics
Basic EPS
$ -8.18$ -3.57$ -22.23$ -137.92$ -95.48
Diluted EPS
$ -8.18$ -3.57$ -22.23$ -137.92$ -95.48
Weighted Average Shares Outstanding
 403.92K 867.42K 266.97K 41.59K 28.78K
Weighted Average Shares Outstanding (Diluted)
 403.92K 867.42K 266.97K 41.59K 28.78K
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History